ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Get up to date on 2024 wash sale rules for Dividend Etfs and how they affect harvesting strategies and reporting requirements.
15,526 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Retirement income from Social Security isn’t a one-size-fits-all number. This deep dive explains what the average ret...
Saliva-based tests promise easy disease detection, but coverage gaps and costs could slow adoption. Here’s how it cou...
Struggling to keep a budget you can actually follow? This guide breaks budgeting tips into actionable steps with real...
Axiom Space has closed a $350 million round to accelerate its private space station project. This milestone highlight...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
A private AI platform invites accredited investors join pre-ipo for early ownership at $0.85 per share, closing March...
As AI moves from training to deployment, the infrastructure behind inference could redefine winning investments. This...
Rowspace closed a $50 million funding round led by Sequoia, aiming to turn fragmented investment data into AI-powered...
Looking for tech stocks with staying power? This guide breaks down how to pick what best tech stocks to hold for the ...
New projections from the CBO signal a coming squeeze: come 2030, the u.s. deficit could reach about 5.9% of GDP as he...